CIK: 1394548 - Address: C/o Sellas Life Sciences Group, Inc., 15 West 38Th Street, 10Th Floor, New York, NY 10018
8 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret115-5-1-15-11218462108
P%wins204020208010047

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

12/4/12 16:23
12/1/12
NGSXNeurogesx IncCAHealthDrugPharmaceutical PreparationsGhiglieri Stephen FCAOExec. VPM.d00.0004586D
5/10/11 19:24
5/6/11
NGSXNeurogesx IncCAHealthDrugPharmaceutical PreparationsGhiglieri Stephen FCAOEVP,COO,P183.03061938I5-69-57-41-23-3-13-2-4-10-36-23-68
12/11/08 13:48
12/10/08
NGSXNeurogesx IncCAHealthDrugPharmaceutical PreparationsGhiglieri Stephen FCAOCFOP11.6701138D-75-46-4461120-5-4-17-22-2286366
12/3/08 16:19
12/1/08
NGSXNeurogesx IncCAHealthDrugPharmaceutical PreparationsGhiglieri Stephen FCAOCFOP.m41.4703838D-76-57-47-1025333-711-29-32277425
11/25/08 14:51
11/21/08
NGSXNeurogesx IncCAHealthDrugPharmaceutical PreparationsGhiglieri Stephen FCAOCFOP31.6002635D-81-64-62-8-31-25-200332718359601
11/20/08 17:34
11/18/08
NGSXNeurogesx IncCAHealthDrugPharmaceutical PreparationsGhiglieri Stephen FCAOCFOP.m51.62031033D-76-58-5162-14-21-8-23-16-15235455
5/14/08 16:12
5/13/08
NGSXNeurogesx IncCAHealthDrugPharmaceutical PreparationsGhiglieri Stephen FCAOCFOM.d221.800127827D-65-58-48-20-73-4-210-5-8-4816
1/3/08 15:50
12/31/07
NGSXNeurogesx IncCAHealthDrugPharmaceutical PreparationsGhiglieri Stephen FCAOCFOM.d141.800810815D-23-241-1783-17-8-43-50-82

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact